The Scientist

» deafness and immunology

Most Recent

image: Why So Soon?

Why So Soon?

By | May 1, 2013

Researchers are using modern experimental tools to probe the mysterious molecular pathways that lead to premature labor and birth.

4 Comments

image: Mimicking Mussels

Mimicking Mussels

By | April 1, 2013

Scientists develop a gel that mimics mollusc glue to coat the insides of blood vessels.

1 Comment

image: Sensing Gene Therapy

Sensing Gene Therapy

By | March 31, 2013

Scientists are using genetic techniques to target diseases that affect how we see, hear, smell, taste, and feel.

1 Comment

image: Antibody-Dependent Enhanced (ADE) Immunity

Antibody-Dependent Enhanced (ADE) Immunity

By | March 2, 2013

The method to the dengue virus's maddening infectiousness.

0 Comments

image: Bedeviled by Dengue

Bedeviled by Dengue

By | March 1, 2013

The global spread of dengue virus has immunologists and public-health experts debating the best way to curb infection.

5 Comments

image: Dual Adaptation in Deaf Brains

Dual Adaptation in Deaf Brains

By | February 12, 2013

The brains of people who cannot hear adapt to process vision-based language, in addition to brain changes associated with the loss of auditory input. 

0 Comments

image: Do Mice Make Bad Models?

Do Mice Make Bad Models?

By | February 11, 2013

A study suggests that some mouse models do not accurately mimic human molecular mechanisms of inflammatory response, but other mouse strains may fare better.

4 Comments

image: New TB Vaccine Fails Trial

New TB Vaccine Fails Trial

By | February 4, 2013

One of the most advanced tuberculosis vaccines has failed to protect infants from getting the disease in a clinical trial, but it may be effective in adults.

1 Comment

image: A Chill Issue

A Chill Issue

By | February 1, 2013

The very cold, the merely chilled, and the colorful

0 Comments

image: Immune to Failure

Immune to Failure

By | February 1, 2013

With dogged persistence and an unwillingness to entertain defeat, Bruce Beutler discovered a receptor that powers the innate immune response to infections—and earned his share of a Nobel Prize.

2 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

  4. Another DNA Vaccine for Zika Shows Promise
RayBiotech